| 000 | 01613 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515230407.0 | ||
| 264 | 0 | _c20100728 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1098-4275 | ||
| 024 | 7 |
_a10.1542/peds.2009-3395 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArdelean, Daniela S | |
| 245 | 0 | 0 |
_aSevere ulcerative colitis after rituximab therapy. _h[electronic resource] |
| 260 |
_bPediatrics _cJul 2010 |
||
| 300 |
_ae243-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 | _aBiopsy, Needle |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xchemically induced |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xdiagnosis |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGonska, Tanja | |
| 700 | 1 | _aWires, Shannon | |
| 700 | 1 | _aCutz, Ernest | |
| 700 | 1 | _aGriffiths, Anne | |
| 700 | 1 | _aHarvey, Elizabeth | |
| 700 | 1 | _aTse, Shirley M L | |
| 700 | 1 | _aBenseler, Susanne M | |
| 773 | 0 |
_tPediatrics _gvol. 126 _gno. 1 _gp. e243-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1542/peds.2009-3395 _zAvailable from publisher's website |
| 999 |
_c19915225 _d19915225 |
||